Ozdamar Melda
Acta Microbiol Immunol Hung. 2020 Mar 9;67(1):73-78. doi: 10.1556/030.2020.01081.
The aim of this study was to detect the frequency of methicillin-resistant Staphylococcus aureus (MRSA) colonization at admission in a group of presumably high-risk international or Turkish patients referred to our center for elective operations, some of whom were from countries with an unknown prevalence of MRSA infection or colonization.
The results of nasal swab screening for MRSA colonization performed using a specific algorithm between 2011 and 2018 in a private medical center were retrospectively reviewed. Presence of MRSA was ascertained using culture and/or real-time polymerase chain reaction (real-time PCR).
A total of 3,795 patients were included in the study. More than half of the patients were ≤19 years of age (2,094, 55.2%), and MRSA positivity was more common among these patients. Turkish patients constituted 24.5% of the study population. International patients were most frequently referred from Iraq (55.92%), Libya (11.44%), Romania (2.69%), and Bulgaria (1.98%). MRSA positivity was significantly more common among patients referred from other countries when compared to Turkish nationals (11.5% vs. 4.4%, P = 0.00001). Countries with the highest prevalence rates of MRSA colonization were as follows with decreasing order: United Arab Emirates, 25.0%; Georgia, 23.1%; Russia, 22.7%; Iraq, 13.0%, Romania, 12.7%. Other countries with high number of admitted patients (>70 patients) had the following MRSA rates: Turkey, 4.4%; Libya, 6.0%; Bulgaria, 5.3%.
Although MRSA has a low prevalence in our center, a variation in the rate of MRSA positivity was observed across patients from different countries. Absence hospital acquired contamination or outbreaks in our institution may be attributed to the screening algorithm used and underscores the importance of risk analysis for patients referred from geographical locations with unknown MRSA frequency, to reduce the risk of transmission.
本研究旨在检测一组因择期手术转诊至我们中心的、推测为高风险的国际患者或土耳其患者入院时耐甲氧西林金黄色葡萄球菌(MRSA)定植的频率,其中一些患者来自MRSA感染或定植患病率未知的国家。
回顾性分析2011年至2018年在一家私立医疗中心使用特定算法进行的鼻拭子MRSA定植筛查结果。通过培养和/或实时聚合酶链反应(实时PCR)确定MRSA的存在。
共有3795例患者纳入研究。超过一半的患者年龄≤19岁(2094例,55.2%),且MRSA阳性在这些患者中更为常见。土耳其患者占研究人群的24.5%。国际患者最常来自伊拉克(55.92%)、利比亚(11.44%)、罗马尼亚(2.69%)和保加利亚(1.98%)。与土耳其国民相比,来自其他国家的患者中MRSA阳性明显更为常见(11.5%对4.4%,P = 0.00001)。MRSA定植患病率最高的国家按降序排列如下:阿拉伯联合酋长国,25.0%;格鲁吉亚,23.1%;俄罗斯,22.7%;伊拉克,13.0%;罗马尼亚,12.7%。其他收治患者数量较多(>70例)的国家的MRSA率如下:土耳其,4.4%;利比亚,6.0%;保加利亚,5.3%。
尽管MRSA在我们中心的患病率较低,但观察到来自不同国家的患者中MRSA阳性率存在差异。我们机构未发生医院获得性污染或暴发可能归因于所使用的筛查算法,并强调了对来自MRSA频率未知地理位置的患者进行风险分析以降低传播风险的重要性。